Unknown

Dataset Information

0

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.


ABSTRACT: Uveal melanoma (UM) is the most common intraocular tumour in adults and despite surgical or radiation treatment of primary tumours, ~50% of patients progress to metastatic disease. Therapeutic options for metastatic UM are limited, with clinical trials having little impact. Here we perform whole-genome sequencing (WGS) of 103 UM from all sites of the uveal tract (choroid, ciliary body, iris). While most UM have low tumour mutation burden (TMB), two subsets with high TMB are seen; one driven by germline MBD4 mutation, and another by ultraviolet radiation (UVR) exposure, which is restricted to iris UM. All but one tumour have a known UM driver gene mutation (GNAQ, GNA11, BAP1, PLCB4, CYSLTR2, SF3B1, EIF1AX). We identify three other significantly mutated genes (TP53, RPL5 and CENPE).

SUBMITTER: Johansson PA 

PROVIDER: S-EPMC7229209 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.

Johansson Peter A PA   Brooks Kelly K   Newell Felicity F   Palmer Jane M JM   Wilmott James S JS   Pritchard Antonia L AL   Broit Natasa N   Wood Scott S   Carlino Matteo S MS   Leonard Conrad C   Koufariotis Lambros T LT   Nathan Vaishnavi V   Beasley Aaron B AB   Howlie Madeleine M   Dawson Rebecca R   Rizos Helen H   Schmidt Chris W CW   Long Georgina V GV   Hamilton Hayley H   Kiilgaard Jens F JF   Isaacs Timothy T   Gray Elin S ES   Rolfe Olivia J OJ   Park John J JJ   Stark Andrew A   Mann Graham J GJ   Scolyer Richard A RA   Pearson John V JV   van Baren Nicolas N   Waddell Nicola N   Wadt Karin W KW   McGrath Lindsay A LA   Warrier Sunil K SK   Glasson William W   Hayward Nicholas K NK  

Nature communications 20200515 1


Uveal melanoma (UM) is the most common intraocular tumour in adults and despite surgical or radiation treatment of primary tumours, ~50% of patients progress to metastatic disease. Therapeutic options for metastatic UM are limited, with clinical trials having little impact. Here we perform whole-genome sequencing (WGS) of 103 UM from all sites of the uveal tract (choroid, ciliary body, iris). While most UM have low tumour mutation burden (TMB), two subsets with high TMB are seen; one driven by g  ...[more]

Similar Datasets

| S-EPMC7583924 | biostudies-literature
| S-EPMC10377706 | biostudies-literature
| S-ECPF-GEOD-33655 | biostudies-other
| S-EPMC9005314 | biostudies-literature
| S-EPMC7661968 | biostudies-literature
| S-EPMC8430821 | biostudies-literature
| S-EPMC8657208 | biostudies-literature
| S-EPMC3621412 | biostudies-other
| S-EPMC3721405 | biostudies-other
| S-EPMC5097942 | biostudies-literature